| John Patrick Walsh, MD | |
|
2600 N Mayfair Rd, Suite 545, Wauwatosa, WI 53226-1309 | |
| (414) 476-0430 | |
| (414) 476-3242 |
| Full Name | John Patrick Walsh |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 2600 N Mayfair Rd, Wauwatosa, Wisconsin |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497723035 | NPI | - | NPPES |
| 340005580 | Other | WI | MEDICARE RAILROAD |
| 30129700 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 17840020 (Wisconsin) | Primary |
| Entity Name | Ascension Medical Group-southeast Wisconsin Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609881077 PECOS PAC ID: 8628980943 Enrollment ID: O20031104000421 |
News Archive
About 25 million Americans who are aging in place rely on help from other people and devices such as canes, raised toilets or shower seats to perform essential daily activities, according to a new study documenting how older adults adapt to their changing physical abilities.
Hospitals that employ more nurse assistants relative to the number of professionally qualified nurses have higher mortality rates, lower patient satisfaction, and poorer quality and safety of care, according to a new European study published today in the leading scientific journal BMJ Quality and Safety.
It is a well-known fact in drug trials that individuals can respond just as well to placebos, sugar pills, as to the active drug.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced the United States Food and Drug Administration (FDA) granted orphan designation for ACE-031 for the treatment of Duchenne Muscular Dystrophy (DMD), a fatal neuromuscular disease in which patients experience a progressive loss of muscle mass and strength. ACE-031 is an investigational protein therapeutic being developed to increase muscle mass and strength.
Unilife Corporation, a developer and supplier of injectable drug delivery systems, today announced its financial results for the quarter ended December 31, 2012, (the second quarter of Fiscal Year 2013).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Patrick Walsh, MD 2600 N Mayfair Rd, Ste 545, Wauwatosa, WI 53226-1309 Ph: (414) 476-0430 | John Patrick Walsh, MD 2600 N Mayfair Rd, Suite 545, Wauwatosa, WI 53226-1309 Ph: (414) 476-0430 |
News Archive
About 25 million Americans who are aging in place rely on help from other people and devices such as canes, raised toilets or shower seats to perform essential daily activities, according to a new study documenting how older adults adapt to their changing physical abilities.
Hospitals that employ more nurse assistants relative to the number of professionally qualified nurses have higher mortality rates, lower patient satisfaction, and poorer quality and safety of care, according to a new European study published today in the leading scientific journal BMJ Quality and Safety.
It is a well-known fact in drug trials that individuals can respond just as well to placebos, sugar pills, as to the active drug.
Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of cells and tissues including muscle, bone, fat, red blood cells and the vasculature, today announced the United States Food and Drug Administration (FDA) granted orphan designation for ACE-031 for the treatment of Duchenne Muscular Dystrophy (DMD), a fatal neuromuscular disease in which patients experience a progressive loss of muscle mass and strength. ACE-031 is an investigational protein therapeutic being developed to increase muscle mass and strength.
Unilife Corporation, a developer and supplier of injectable drug delivery systems, today announced its financial results for the quarter ended December 31, 2012, (the second quarter of Fiscal Year 2013).
› Verified 2 days ago
William H Annesley Jr., MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1547 Upper Pkwy S, Wauwatosa, WI 53213 Phone: 414-254-5610 Fax: 414-755-7576 | |
Kohldon Carter Boydston, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2600 N Mayfair Rd Ste 545, Wauwatosa, WI 53226 Phone: 414-476-0430 | |
Christopher John Walsh, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 2600 N Mayfair Rd, Ste 545, Wauwatosa, WI 53226 Phone: 414-476-0430 Fax: 414-476-3242 |